BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo

  • Kim, Eun-A (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine) ;
  • Hahn, Hoh-Gyu (Life Sciences, Korea Institute of Science and Technology) ;
  • Kim, Tae-Ue (Biomedical Laboratory Science, Yonsei University) ;
  • Choi, Soo-Young (Biomedical Sciences and Research Institute for Bioscience and Biotechnology, Hallym University) ;
  • Cho, Sung-Woo (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
  • Received : 2010.03.30
  • Accepted : 2010.04.08
  • Published : 2010.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Beta-Amyloid ($A{\beta}$)-induced neuroinflammation is one of the key events in the development of neurodegenerative disease. We previously reported that KHG21834, a benzothiazole derivative, attenuates $A{\beta}$-induced degeneration of cortical and mesencephalic neurons in vitro. In the present work, we show that KHG21834 reduces $A{\beta}$-mediated neuroinflammation in brain. In vivo intracerebroventricular infusion of KHG21834 leads to decreases in the numbers of activated astrocytes and microglia and level of proinflammatory cytokines such as interleukin-$1{\beta}$ and tumor necrosis factor-$\alpha$ induced by $A{\beta}$ in the hippocampus. This suppression of neuroinflammation is associated with decreased neuron loss, restoration of synaptic dysfunction biomarkers in the hippocampus to control level, and diminished amyloid deposition. These results may suggest the potential therapeutic efficacy of KHG21834 for the treatment of $A{\beta}$-mediated neuroinflammation.

Keywords

References

  1. Breitner, J. C. (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47, 401-411. https://doi.org/10.1146/annurev.med.47.1.401
  2. Eikelenboom, P. and Gool, W. A. (2004) Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J. Neural. Transm. 111, 281-294. https://doi.org/10.1007/s00702-003-0055-1
  3. Raine, C. S. (1994) Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53, 328-337. https://doi.org/10.1097/00005072-199407000-00002
  4. Matyszak, M. K. (1998) Inflammation in the CNS: balance between immunological privilege and immune responses. Prog. Neurobiol. 56, 19-35. https://doi.org/10.1016/S0301-0082(98)00014-8
  5. Giulian, D. (1999) Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 65, 13-18. https://doi.org/10.1086/302477
  6. Gonzalez-Scarano, F. and Baltuch, G. (1999) Microglia as mediators of infammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240. https://doi.org/10.1146/annurev.neuro.22.1.219
  7. Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B. and Hong, J. S. (2002) Microglia enhance ${\beta}$-amyloid peptide- induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973-983. https://doi.org/10.1046/j.1471-4159.2002.01210.x
  8. Combs, C. K., Karlo, J. C., Kao, S. C. and Landreth, G. E. (2001) ${\beta}$-amyloid stimulation of microglia and monocytes results in TNF${\alpha}$-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
  9. Gao, H. M., Jiang, J., Wilson, B., Zhang, W. Q., Hong, J. S. and Liu, B. (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 1285-1297. https://doi.org/10.1046/j.1471-4159.2002.00928.x
  10. Liu, Y., Qin, L., Wilson, B. C., An, L., Hong, J. S. and Liu, B. (2002) Inhibition by Naloxone stereoisomers of ${\beta}$-amyloid peptide (1-42) induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302, 1212-1219. https://doi.org/10.1124/jpet.102.035956
  11. Knethen, A., Brockhaus, F., Kleiter, I. and Brune, B. (1999) NO-evoked macrophage apoptosis is attenuated by cAMP-induced gene expression. Mol. Med. 5, 672-684.
  12. Heneka, M. T., Loschmann, P. A., Gleichmann, M., Weller, M., Schulz, J. B., Wullner, U. and Klockgether, T. (1998) Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J. Neurochem. 71, 88-94. https://doi.org/10.1046/j.1471-4159.1998.71010088.x
  13. Korhonen, R., Lahti, A., Kankaanranta, H. and Molanen, E. (2005) Nitric oxide production and signalling in inflammation. Curr. Drug Targets Inflamm. Allergy 4, 471-479. https://doi.org/10.2174/1568010054526359
  14. Kleinert, H., Schwarz, P. M. and Forstermann, U. (2003) Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384, 1343-1364. https://doi.org/10.1515/BC.2003.152
  15. Bhat, N. R., Zhang, P., Lee, J. C. and Hogan, E. L. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-${\alpha}$ gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
  16. Ajizian, S. J., English, B. K. and Meals, E. A. (1999) Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179, 939-944. https://doi.org/10.1086/314659
  17. Carter, A. B., Monick, M. M. and Hunninghake, G. W. (1999) Both Erk and p38 Kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell. Mol. Biol. 20, 751-758. https://doi.org/10.1165/ajrcmb.20.4.3420
  18. Moore, A. H. and O’Banion, M. K. (2002) Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease. Adv. Drug Deliv. Rev. 54, 1627-1656. https://doi.org/10.1016/S0169-409X(02)00162-X
  19. Wang, M. J., Lin, W. W., Chen, H. L., Chang, Y. H., Ou, H. C., Kuo, J. S., Hong, J. S. and Jeng, K. C. (2002) Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur. J. Neurosci. 16, 2103-2112. https://doi.org/10.1046/j.1460-9568.2002.02290.x
  20. Allan, S. M., Tyrrell, P. J. and Rothwell, N. J. (2005) Interleukin-1${\beta}$ and neuronal injury. Nat. Rev. Immunol. 5, 629-640. https://doi.org/10.1038/nri1664
  21. Emsley, H. C. A., Smith, C. J., Georgiou, R. F., Vail, A., Hopkins, S. J., Rothwell, N. J. and Tyrrell, P. J. (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76, 1366-1372. https://doi.org/10.1136/jnnp.2004.054882
  22. Heiser, V., Engemann, S., Brocker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., Herhaus, C., Barnickel, G., Bottcher, H., Lehrach, H. and Wanker, E. E. (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. U.S.A. 99, 16400-16406. https://doi.org/10.1073/pnas.182426599
  23. Ishiyama, T., Okada, R., Nishibe, H., Mitsumoto, H. and Nakayama, C. (2004) Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res. 1019, 226-236. https://doi.org/10.1016/j.brainres.2004.06.002
  24. Mortimer, C. G., Wells, G., Crochard, J. P., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G. and Westwell, A. D. (2006) Antitumor Benzothiazoles. $26.^{1}$ 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J. Med. Chem. 49, 179-185. https://doi.org/10.1021/jm050942k
  25. Pietrancosta, N., Moumen, A., Dono, R., Lingor, P., Planchamp, V., Lamballe, F., Bahr, M., Kraus, J. L. and Maina, F. (2006) Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. J. Med. Chem. 49, 3645-3652. https://doi.org/10.1021/jm060318n
  26. Mathis, C. A., Bacskai, B. J., Kajdasz, S. T., Mclellan, M. E., Frosch, M. P., Hyman, B. T., Holt, D. P., Wang, Y., Huang, G. F., Debnath, M. L. and Klunk, W. E. (2002) A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 12, 295-298. https://doi.org/10.1016/S0960-894X(01)00734-X
  27. Klunk, W. E., Wang, Y., Huang, G., Debnath, M. L., Holt, D. P., Shao, L., Hamilton, R. L., Ikonomovic, M. D., DeKosky, S. T. and Mathis, C. A. (2003) The binding of 2-(4'-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 23, 2086-2092.
  28. Choi, M. M., Kim, E. A., Hahn, H. G., Nam, K. D., Yang, S. J., Choi, S. Y., Kim, T. U., Cho, S. W. and Huh, J. W. (2007) Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239, 156-166. https://doi.org/10.1016/j.tox.2007.07.010
  29. Kim, E. A., Kim, H., Ahn, J. Y., Hahn, H. G., Kim, K. S., Kim, T. U. and Cho, S. W. (2010) Suppression of lipopolysaccharide-induced microglial activation by a benzothiazole derivative. Mol. Cells (in press)
  30. Small, D. H., Mok, S. S. and Bornstein, J. C. (2001) Alzheimer's disease and A${\beta}$ toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595-598. https://doi.org/10.1038/35086072
  31. Sebastiani, G., Morisette, C., Lagace, C., Boule, M., Quollette, M. J., McLaughin, R. W., Lacombe, D., Cervais, F. and Trembley, P. (2006) The cAMP-specific phosphodiesterase 4B mediates A${\beta}$-induced microglial activation. Neurobiol. Aging 27, 691-701. https://doi.org/10.1016/j.neurobiolaging.2005.03.024
  32. White, J. A., Manelli, A. M., Holmberg, K. H., Van Eldik, L. J. and Ladu, M. J. (2005) Differential effects of oligomeric and fibrillar amyloid-beta1-42 on astrocyte-mediated inflammation. Neurobiol. Dis. 18, 459-465. https://doi.org/10.1016/j.nbd.2004.12.013
  33. Craft, J. M., Van Eldik, L. J., Zasadzki, M., Hu, W. and Watterson, D. M. (2004) Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human ${\beta}$-amyloid in a murine model of neuroinflammation. J. Mol. Neurosci. 24, 115-122. https://doi.org/10.1385/JMN:24:1:115
  34. Craft. J. M., Watterson, D. M., Frautschy, S. A. and Van Eldik, L. J. (2004) Aminopyridazines inhibit ${\beta}$-amyloid-induced glial activation and neuronal damage in vivo. Neurobiol. Aging 25, 1283-1292. https://doi.org/10.1016/j.neurobiolaging.2004.01.006
  35. Craft, J. M., Watterson, D. M., Hirsch, E. and Van Eldik, L. J. (2005) Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human ${\beta}$-amyloid. J. Neuroinflammation 2, 15-23. https://doi.org/10.1186/1742-2094-2-15
  36. Craft, J. M., Watterson, D. M., Marks, A. and Van Eldik, L. J. (2005) Enhanced susceptibility of S100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human ${\beta}$-amyloid. Glia 51, 209-216. https://doi.org/10.1002/glia.20194
  37. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R. and McGeer, P. L. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421. https://doi.org/10.1016/S0197-4580(00)00124-X
  38. Ranaivo, H. R., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Eldik, L. J. V. and Watterson, D. M. (2006) Glia as a therapeutic target: selective suppression of human amyloid-${\beta}$-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26, 662-670. https://doi.org/10.1523/JNEUROSCI.4652-05.2006
  39. Cheramy, A., Barbeito, L., Godeheu, G. and Glowinski, J. (1992) Riluzole inhibits release of glutamate in the caudate nucleus of the cat in vitro. Neurosci. Lett. 147, 209-212. https://doi.org/10.1016/0304-3940(92)90597-Z
  40. Frautschy, S. A., Yang, F., Calderon, L. and Cole, G. M. (1996) Rodent models of Alzheimer’s disease: rat A${\beta}$ infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311-321. https://doi.org/10.1016/0197-4580(95)02073-X
  41. Laursen, S. E. and Belknap, J. K. (1986) Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods 16, 355-357. https://doi.org/10.1016/0160-5402(86)90038-0

Cited by

  1. Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain vol.46, pp.7, 2013, https://doi.org/10.5483/BMBRep.2013.46.7.018
  2. Water-soluble ferulic acid derivatives improve amyloid-β-induced neuronal cell death and dysmnesia through inhibition of amyloid-β aggregation vol.80, pp.3, 2016, https://doi.org/10.1080/09168451.2015.1107463
  3. Neuroprotective Effects of 2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Against Oxidative Stress vol.31, pp.7, 2011, https://doi.org/10.1007/s10571-011-9713-2
  4. P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP vol.5, pp.3, 2014, https://doi.org/10.1038/cddis.2014.79
  5. Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on glutamate-induced neurotoxicity in rat brain vol.38, 2013, https://doi.org/10.1016/j.neuro.2013.07.001
  6. Antioxidative effects of ethyl 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate against amyloid β-induced oxidative cell death via NF-κB, GSK-3β and β-catenin signaling pathways in cultured cortical neurons vol.49, pp.4, 2015, https://doi.org/10.3109/10715762.2015.1007048